Navigation

2004/038 NICE issues guidance on the use of tacrolimus and pimecrolimus alongside advice on how frequently topical corticosteroids should be applied for atopic eczema

The National Institute for Clinical Excellence (NICE) has today issued guidance to the NHS in England and Wales on the use of tacrolimus and pimecrolimus to treat moderate to severe atopic eczema in adults.  NICE has also issued guidance on how frequently topical corticosteroids should be applied when treating atopic eczema in children and adults.

This page was last updated: 03 August 2007

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.